159 related articles for article (PubMed ID: 34173819)
1. Use of hair products in relation to ovarian cancer risk.
White AJ; Sandler DP; Gaston SA; Jackson CL; O'Brien KM
Carcinogenesis; 2021 Oct; 42(9):1189-1195. PubMed ID: 34173819
[TBL] [Abstract][Full Text] [Related]
2. Use of Straighteners and Other Hair Products and Incident Uterine Cancer.
Chang CJ; O'Brien KM; Keil AP; Gaston SA; Jackson CL; Sandler DP; White AJ
J Natl Cancer Inst; 2022 Dec; 114(12):1636-1645. PubMed ID: 36245087
[TBL] [Abstract][Full Text] [Related]
3. Hair dye and chemical straightener use and breast cancer risk in a large US population of black and white women.
Eberle CE; Sandler DP; Taylor KW; White AJ
Int J Cancer; 2020 Jul; 147(2):383-391. PubMed ID: 31797377
[TBL] [Abstract][Full Text] [Related]
4. Adolescent use of hair dyes, straighteners and perms in relation to breast cancer risk.
White AJ; Gregoire AM; Taylor KW; Eberle C; Gaston S; O'Brien KM; Jackson CL; Sandler DP
Int J Cancer; 2021 May; 148(9):2255-2263. PubMed ID: 33252833
[TBL] [Abstract][Full Text] [Related]
5. Hair product use and breast cancer incidence in the Black Women's Health Study.
Coogan PF; Rosenberg L; Palmer JR; Cozier YC; Lenzy YM; Bertrand KA
Carcinogenesis; 2021 Jul; 42(7):924-930. PubMed ID: 34013957
[TBL] [Abstract][Full Text] [Related]
6. Hair relaxer use and risk of uterine cancer in the Black Women's Health Study.
Bertrand KA; Delp L; Coogan PF; Cozier YC; Lenzy YM; Rosenberg L; Palmer JR
Environ Res; 2023 Dec; 239(Pt 1):117228. PubMed ID: 37821068
[TBL] [Abstract][Full Text] [Related]
7. Hair relaxers not associated with breast cancer risk: evidence from the black women's health study.
Rosenberg L; Boggs DA; Adams-Campbell LL; Palmer JR
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1035-7. PubMed ID: 17507635
[TBL] [Abstract][Full Text] [Related]
8. Associations between Personal Care Product Use Patterns and Breast Cancer Risk among White and Black Women in the Sister Study.
Taylor KW; Troester MA; Herring AH; Engel LS; Nichols HB; Sandler DP; Baird DD
Environ Health Perspect; 2018 Feb; 126(2):027011. PubMed ID: 29467107
[TBL] [Abstract][Full Text] [Related]
9. Use of Chemical Hair Straighteners and Fecundability in a North American Preconception Cohort.
Wise LA; Wang TR; Ncube CN; Lovett SM; Abrams J; Boynton-Jarrett R; Koenig MR; Geller RJ; Wesselink AK; Coleman CM; Hatch EE; James-Todd T
Am J Epidemiol; 2023 Jul; 192(7):1066-1080. PubMed ID: 37005071
[TBL] [Abstract][Full Text] [Related]
10. Hair product use and breast cancer risk among African American and White women.
Llanos AAM; Rabkin A; Bandera EV; Zirpoli G; Gonzalez BD; Xing CY; Qin B; Lin Y; Hong CC; Demissie K; Ambrosone CB
Carcinogenesis; 2017 Sep; 38(9):883-892. PubMed ID: 28605409
[TBL] [Abstract][Full Text] [Related]
11. Personal use of permanent hair dyes and cancer risk and mortality in US women: prospective cohort study.
Zhang Y; Birmann BM; Han J; Giovannucci EL; Speizer FE; Stampfer MJ; Rosner BA; Schernhammer ES
BMJ; 2020 Sep; 370():m2942. PubMed ID: 32878860
[TBL] [Abstract][Full Text] [Related]
12. Hair relaxer use and risk of uterine leiomyomata in African-American women.
Wise LA; Palmer JR; Reich D; Cozier YC; Rosenberg L
Am J Epidemiol; 2012 Mar; 175(5):432-40. PubMed ID: 22234483
[TBL] [Abstract][Full Text] [Related]
13. Skin lighteners and hair relaxers as risk factors for breast cancer: results from the Ghana breast health study.
Brinton LA; Figueroa JD; Ansong D; Nyarko KM; Wiafe S; Yarney J; Biritwum R; Brotzman M; Thistle JE; Adjei E; Aitpillah F; Dedey F; Edusei L; Titiloye N; Awuah B; Clegg-Lamptey JN; Wiafe-Addai B; Vanderpuye V
Carcinogenesis; 2018 Apr; 39(4):571-579. PubMed ID: 29324997
[TBL] [Abstract][Full Text] [Related]
14. Use of permanent hair dyes and risk of breast cancer.
Green A; Willett WC; Colditz GA; Stampfer MJ; Bain C; Rosner B; Hennekens CH; Speizer FE
J Natl Cancer Inst; 1987 Aug; 79(2):253-7. PubMed ID: 3474457
[TBL] [Abstract][Full Text] [Related]
15. Association of Powder Use in the Genital Area With Risk of Ovarian Cancer.
O'Brien KM; Tworoger SS; Harris HR; Anderson GL; Weinberg CR; Trabert B; Kaunitz AM; D'Aloisio AA; Sandler DP; Wentzensen N
JAMA; 2020 Jan; 323(1):49-59. PubMed ID: 31910280
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of reproductive factors and exogenous hormone use in relation to ovarian cancer risk among Black women.
Bethea TN; Palmer JR; Adams-Campbell LL; Rosenberg L
Cancer Causes Control; 2017 May; 28(5):385-391. PubMed ID: 28025764
[TBL] [Abstract][Full Text] [Related]
17. Associations between use of chemical hair products and epigenetic age: Findings from the Sister Study.
Chang CJ; O'Brien KM; Kresovich JK; Nwanaji-Enwerem JC; Xu Z; Gaston SA; Jackson CL; Sandler DP; Taylor JA; White AJ
Environ Epidemiol; 2024 Jun; 8(3):e311. PubMed ID: 38799263
[TBL] [Abstract][Full Text] [Related]
18. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC
BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920
[TBL] [Abstract][Full Text] [Related]
19. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies.
Rice MS; Hankinson SE; Tworoger SS
Fertil Steril; 2014 Jul; 102(1):192-198.e3. PubMed ID: 24825424
[TBL] [Abstract][Full Text] [Related]
20. Endocrine disrupting chemical-associated hair product use during pregnancy and gestational age at delivery: a pilot study.
Preston EV; Fruh V; Quinn MR; Hacker MR; Wylie BJ; O'Brien K; Mahalingaiah S; James-Todd T
Environ Health; 2021 Jul; 20(1):86. PubMed ID: 34320990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
